Nutriband Inc NTRB
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-06-20 |
| Shares Out. | 12,160,000 |
| Website | nutriband.com/ ↗ |
| Phone | 14073776695 |
| Employees | 3 |
| Revenue | $433,399 |
| Gross Profit | $196,801 |
| Net Income | -$1.2M |
| Free Cash Flow | -$4.4M |
| Total Assets | $6.9M |
| Total Liabilities | $902,312 |
| Equity | $6.0M |
About Nutriband Inc
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Nutriband Inc is a publicly traded company under the ticker symbol NTRB on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)